Clinical Trial

Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes

Recruiting
View on ClinicalTrials.gov →
Summary
This research study aims to evaluate the effect of treatment delivery method on voice outcomes over 12 months in people with a primary complaint of a voice problem, diagnosed with either non-phonotraumatic vocal hyperfunction, also known as primary muscle tension dysphonia (MTD) or phonotraumatic vocal hyperfunction, also known as benign vocal fold lesions (lesions). The secondary objectives are: * To evaluate acoustic correlates of clear speech and the relationship to vocal acoustic and patient-reported voice outcomes. * To determine the association between overall dysphonia outcomes and adoption of clear speech.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-09.
Status change: Not Yet Recruiting → Recruiting 2025-10-15
Trial Details
NCT Number NCT07176988
Lead Sponsor Emory University
Collaborators: National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions Dysphonia, Primary Muscle Tension Dysphonia (MTD)
Enrollment 120 participants
Start Date 2025-09-03
Primary Completion 2029-04 (estimated)
Study Completion 2029-04 (estimated)
Updated on ClinicalTrials.gov 2025-10-20